Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results

Authors: Thomas, D., Hickish, T. et al.

Journal: CANCER RESEARCH

Volume: 80

Issue: 4

eISSN: 1538-7445

ISSN: 0008-5472

DOI: 10.1158/1538-7445.SABCS19-OT3-17-03

Source: Web of Science (Lite)